130 related articles for article (PubMed ID: 1880786)
1. Alteration in de novo pyrimidine biosynthesis during uridine reversal of pyrazofurin-inhibited DNA synthesis.
Ringer DP; Howell BA; Etheredge JL
J Biochem Toxicol; 1991; 6(1):19-27. PubMed ID: 1880786
[TBL] [Abstract][Full Text] [Related]
2. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
Karle JM; Cowan KH; Chisena CA; Cysyk RL
Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of Plasmodium falciparum by pyrazofurin, an inhibitor of pyrimidine biosynthesis de novo.
Scott HV; Gero AM; O'Sullivan WJ
Mol Biochem Parasitol; 1986 Jan; 18(1):3-15. PubMed ID: 3515174
[TBL] [Abstract][Full Text] [Related]
4. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
5. Assessment of salvage pathways utilized for incorporation of exogenous pyrimidine nucleosides into DNA of guinea pig lymphocytes stimulated by Con A.
Ringer DP; Howell BA; Etheredge JL; Clouse JA; Kizer DE
FEBS Lett; 1987 Nov; 224(1):59-64. PubMed ID: 3500072
[TBL] [Abstract][Full Text] [Related]
6. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
Cadman E; Benz C
Biochim Biophys Acta; 1980 Oct; 609(3):372-82. PubMed ID: 7437431
[TBL] [Abstract][Full Text] [Related]
7. Uridine as the only alternative to pyrimidine de novo synthesis in rat T lymphocytes.
Bismuth G; Thuillier L; Perignon JL; Cartier PH
FEBS Lett; 1982 Nov; 148(1):135-9. PubMed ID: 6983457
[TBL] [Abstract][Full Text] [Related]
8. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
Seymour KK; Lyons SD; Phillips L; Rieckmann KH; Christopherson RI
Biochemistry; 1994 May; 33(17):5268-74. PubMed ID: 7909690
[TBL] [Abstract][Full Text] [Related]
10. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of UMP synthase protein and mRNA in pyrazofurin-resistant rat hepatoma cells.
Suttle DP
J Biol Chem; 1983 Jun; 258(12):7707-13. PubMed ID: 6134725
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pyrazofurin-resistant HeLa cells with amplification of UMP synthase gene.
Kanalas JJ; Hutton JJ; Suttle DP
Somat Cell Mol Genet; 1985 Jul; 11(4):359-69. PubMed ID: 3860966
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of orotidylate decarboxylase by 4(5H)-oxo-1-beta-D-ribofuranosylpyrazolo[3,4-d] pyrimidine-3-thiocarboxamide (APR-TC) in B lymphoblasts. Activation by adenosine kinase.
Dee Nord L; Willis RC; Smee DF; Riley TA; Revankar GR; Robins RK
Biochem Pharmacol; 1988 Dec; 37(24):4697-705. PubMed ID: 2849455
[TBL] [Abstract][Full Text] [Related]
14. Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinoma, and xenografts.
Ahmed NK
Cancer; 1984 Oct; 54(7):1370-3. PubMed ID: 6088027
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
Plagemann PG; Behrens M; Abraham D
Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095).
Plagemann PG; Behrens M
Cancer Res; 1976 Oct; 36(10):3807-12. PubMed ID: 182363
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
[TBL] [Abstract][Full Text] [Related]
18. Amplification of the UMP synthase gene and enzyme overproduction in pyrazofurin-resistant rat hepatoma cells. Molecular cloning of a cDNA for UMP synthase.
Kanalas JJ; Suttle DP
J Biol Chem; 1984 Feb; 259(3):1848-53. PubMed ID: 6546385
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells.
Pérignon JL; Bories DM; Houllier AM; Thuillier L; Cartier PH
Biochim Biophys Acta; 1987 Apr; 928(2):130-6. PubMed ID: 3567226
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).
Peters GJ; Sharma SL; Laurensse E; Pinedo HM
Invest New Drugs; 1987; 5(3):235-44. PubMed ID: 2822596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
